Genomics Market Growth Opportunity by 2025 - A Comprehensive Analysis states that industry is growing with a CAGR of 10.8% with $32,995.3 Million in Forecast Period

Genomics uses a mixture of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the structure and function of genomes. For instance, in July 2018, Innovate UK, the UK’s innovation agency, funded approximately US$ 1.76 million (£1.3 million) project, Evonetix Ltd, (UK) that will be in partnership with Durham University. The funds will be utilized for the development of a new enzymatic approach to DNA synthesis. Similarly, in April 2018, DNA Script received approximately US$5.5 million in grant funds from the European Commission and Bpifrance (French investment bank). The technology platform, and other related resources are helping the company to accelerate the development of the genomes. The large-scale Genome Centers will present the All of Us genomics platform.

The global genomics market is expected to reach US$ 32,995.3 Mn in 2025 from US$ 14,728.6 in 2017. The market is estimated to grow with a CAGR of 10.8% from 2018-2025.

Genomics Market to 2025 - Global Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, and Others), Product & Service (Instruments/Systems, Consumables, and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research, and Others) End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Others) and Geography

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPTE100000730

The genomics is defined as the study of a gene and its functioning. The concept of genomics is aimed to understand the architecture of the genome which is comprised of the deoxyribo nucleic acid (DNA), ribo nucleic acid (RNA) and proteins. Genomics is meant to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The report would be of an interest to various stakeholders operating in the genomics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

Key Players Influencing Genomics Market -
1. Thermo Fisher Scientific Inc.
2. Illumina Inc.
3. Eurofins
4. Qiagen
5. Agilent Technologies
6. BGI
7. Bio-Rad Laboratories, Inc.
8. F. Hoffmann-La Roche AG
9. Danaher
10. GE Healthcare

The report analyzes factors affecting genomics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key genomics manufacturing companies along with their SWOT analysis and market strategies.

Have Queries? Ask us at https://www.theinsightpartners.com/inquiry/TIPTE100000730

Key Benefits-

• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Genomics market
• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

Major Market Development-
-In 2016, Twist Bioscience raised its revenue with US$ 61 million for the scale-up and commercial operation of the silicon chip-based high throughput low-cost gene synthesis platform. Similarly, In March 2018, SynbiCITE (UK) received around US$ 17.6 million (£13M) grants and US$ 318.5 million (£234M) private investment. Notably, SynbiCITE is made for increasing synbio applications in the UK. Thus, a huge investments made by the government, companies is anticipated to increase the growth of the global genomics market over the forecast years.
-The developments by the companies are developing technologies and services and are investing more for the research and developments. For instance, Thermo Fisher Scientific Inc. invested 3.7%, 4.1% and 4.2% of its total revenue on R&D activity in 2015, 2016 and 2017 respectively. Since the last three years, the company is focusing on research and development activities which is indicated by increasing R&D expenditure. Therefore, the company strives towards technological developments thereby offering new products in the market.

The developments by the companies are developing technologies and services and are investing more for the research and developments. For instance, Thermo Fisher Scientific Inc. invested 3.7%, 4.1% and 4.2% of its total revenue on R&D activity in 2015, 2016 and 2017 respectively. Since the last three years, the company is focusing on research and development activities which is indicated by increasing R&D expenditure. Therefore, the company strives towards technological developments thereby offering new products in the market.

Buy this Report at https://www.theinsightpartners.com/buy/TIPTE100000730

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

This release was published on openPR.